ReviewFuture oncology (London, England)2025

Alpha radioligand therapy in neuroendocrine neoplasms: current landscape and spotlight on RYZ101.

Udhayvir S Grewal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.